Supporting the designation of May 2023 as "National Brain Tumor Awareness Month".

Subjects: Health, Cancer, Commemorative events and holidays, Congressional tributes, Health care quality, Health promotion and preventive care, Medical research, Neurological disorders, Research administration and funding

Summary:  <p>This resolution supports the designation of National Brain Tumor Awareness Month.</p>

<html><body><pre>[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 355 Introduced in House (IH)]

&lt;DOC&gt;






118th CONGRESS
  1st Session
H. RES. 355

   Supporting the designation of May 2023 as ``National Brain Tumor 
                           Awareness Month''.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 2, 2023

 Mr. Quigley (for himself, Mr. McCaul, Mr. Fitzpatrick, Ms. Crockett, 
 and Mr. Bacon) submitted the following resolution; which was referred 
                to the Committee on Energy and Commerce

_______________________________________________________________________

                               RESOLUTION


 
   Supporting the designation of May 2023 as ``National Brain Tumor 
                           Awareness Month''.

Whereas more than an estimated 94,390 individuals will be diagnosed with a 
        primary brain tumor in the United States in 2023, and an estimated 
        93,470 individuals in the United States were diagnosed with a primary 
        brain tumor in 2022;
Whereas an estimated 1,000,000 individuals are living with a brain tumor in the 
        United States;
Whereas, in the United States, brain tumors are the--

    (1) leading cause of death from cancer in children who are under 14 
years of age and teens who are under 19 years of age; and

    (2) second leading cause of death from cancer in young adults who are 
between 15 and 39 years of age;

Whereas the average 5-year survival rate for an individual in the United States 
        following the diagnosis of a primary malignant brain tumor is only 35.7 
        percent;
Whereas it is estimated that 18,990 individuals in the United States will die as 
        a result of a malignant brain tumor in 2023;
Whereas brain tumors may be malignant or benign but can be life-threatening in 
        either case;
Whereas treatment of brain tumors is complicated by the fact that more than 100 
        types of brain tumors exist;
Whereas the treatment and removal of brain tumors present significant challenges 
        due to the uniquely complex and fragile nature of the brain;
Whereas brain tumors affect the primary organ in the human body that controls 
        not only cognitive ability, but the actions of every other organ and 
        limb in the body, leading to brain tumors being described as a disease 
        that affects the whole individual;
Whereas brain tumor research is supported by a number of private, nonprofit 
        research foundations and by Federal medical research institutions;
Whereas basic research may fuel advancements and development of new treatments 
        for brain tumors;
Whereas obstacles to the development of new treatments for brain tumors remain, 
        and there are limited strategies for the screening or early detection of 
        brain tumors;
Whereas, despite the high number of individuals diagnosed with a brain tumor 
        every year and the devastating prognoses for those individuals, only 5 
        drugs and 1 medical device are approved by the Food and Drug 
        Administration to treat primary brain tumors;
Whereas the mortality rates associated with brain tumors have changed little 
        during the 30-year period preceding the date of introduction of this 
        resolution;
Whereas there is a need for greater public awareness of brain tumors, including 
        the difficulties associated with research on brain tumors and the 
        opportunities for advances in brain tumor research and treatment; and
Whereas May 2023, during which brain tumor advocates nationwide unite in 
        awareness, outreach, and advocacy activities, is an appropriate month to 
        recognize as ``National Brain Tumor Awareness Month'': Now, therefore, 
        be it
    Resolved, That the House of Representatives--
            (1) supports the designation of ``National Brain Tumor 
        Awareness Month'';
            (2) encourages increased public awareness of brain tumors 
        to honor the individuals who have lost their lives to a brain 
        tumor or currently live with a brain tumor diagnosis;
            (3) supports efforts to develop better treatments for brain 
        tumors that will improve the quality of life and the long-term 
        prognoses of individuals diagnosed with a brain tumor;
            (4) expresses its support for individuals who are battling 
        brain tumors, as well as the families, friends, and caregivers 
        of those individuals; and
            (5) urges a collaborative approach to brain tumor research, 
        which is a promising means of advancing understanding of, and 
        treatment for, brain tumors.
                                 &lt;all&gt;
</pre></body></html>